Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Losartan

    Client Email Product

    Losartan

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    105
    US DMFs Filed

    US DMFs Filed

    46
    CEP/COS Certifications

    CEP/COS Certifications

    36
    JDMFs Filed

    JDMFs Filed

    19
    Other Certificates

    Other Certificates

    28
    Other Suppliers

    Other Suppliers

    56
    API REF. PRICE (USD / KG)
    82

    API Market Place

    33
    INTERMEDIATES
    23
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    125
    Europe

    Europe

    443
    Canada

    Canada

    45
    Australia

    Australia

    0

    South Africa

    South Africa

    66
    Uploaded Dossiers

    Uploaded Dossiers

    162
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    2,263.00

    Annual Reports

    453.00

    FDF Market Place

    8
    EXCIPIENTS
    253
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    3

    News

    116
    REF STANDARD

    EDQM

    3

    USP

    4

    JP

    6

    Other Listed Suppliers

    12
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - 100MG
    • TABLET;ORAL - 25MG
    • TABLET;ORAL - 50MG
    • TABLET;ORAL - 12.5MG;100MG
    • TABLET;ORAL - 12.5MG;50MG
    • TABLET;ORAL - 25MG;100MG
    Full View ScreenFull Screen View
    Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
    Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)

    https://www.businesswire.com/news/home/20231022313600/en

    BUSINESSWIRE
    23 Oct 2023
    Share Share
    MSN's Generic Losartan Potassium Receives Approval in the U.S.
    MSN's Generic Losartan Potassium Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217396

    FDA
    14 Aug 2023
    Share Share
    Enforcement Report - Week of July 12, 2023
    Enforcement Report - Week of July 12, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-12-2023-4244.pdf

    FDA
    12 Jul 2023
    Share Share
    Granules gets FDA nod to market generic medication to treat high blood pressure
    Granules gets FDA nod to market generic medication to treat high blood pressure

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-gets-usfda-nod-to-market-generic-medication-to-treat-high-blood-pressure/articleshow/98266468.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    27 Feb 2023
    Share Share
    IOL Chemicals secures patent for invention related to preparation of Sartan drugs
    IOL Chemicals secures patent for invention related to preparation of Sartan drugs

    https://www.business-standard.com/article/news-cm/iol-chemicals-secures-patent-for-invention-related-to-preparation-of-sartan-drugs-122112400926_1.html

    BUSINESS-STANDARD
    27 Nov 2022
    Share Share
    Enforcement Report - Week of July 6, 2022
    Enforcement Report - Week of July 6, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-6-2022-1657105109.pdf

    FDA
    06 Jul 2022
    Share Share
    Strides Pharma recalls over 6L bottles of blood pressure treatment tablets in US
    Strides Pharma recalls over 6L bottles of blood pressure treatment tablets in US

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-recalls-over-6-lakh-bottles-of-blood-pressure-treatment-tablets-in-us/articleshow/92158435.cms

    ECONOMIC TIMES
    12 Jun 2022
    Share Share
    Enforcement Report - Week of June 8, 2022
    Enforcement Report - Week of June 8, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-8-2022-1654674832.pdf

    FDA
    08 Jun 2022
    Share Share
    Enforcement Report - Week Of June 01, 2022
    Enforcement Report - Week Of June 01, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-01-2022-1654158193.pdf

    FDA
    01 Jun 2022
    Share Share
    Enforcement Report - Week of May 11, 2022
    Enforcement Report - Week of May 11, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-11-2022-1652250109.pdf

    PRESS RELEASE
    11 May 2022
    Share Share
    Enforcement Report - Week of May 4, 2022
    Enforcement Report - Week of May 4, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-4-2022-1651646484.pdf

    FDA
    04 May 2022
    Share Share
    IPC flags safety alert against blood pressure drug, Losartan
    IPC flags safety alert against blood pressure drug, Losartan

    http://www.pharmabiz.com/NewsDetails.aspx?aid=146255&sid=1

    PHARMABIZ
    08 Mar 2022
    Share Share
    Common blood pressure drug does not slow down the progression of more
    Common blood pressure drug does not slow down the progression of more

    https://www.sciencedaily.com/releases/2021/11/211115123531.htm

    SCIENCEDAILY
    15 Nov 2021
    Share Share
    Health Canada Issues Recall of Auro Pharma's Losartan 25/50/100mg tablets
    Health Canada Issues Recall of Auro Pharma's Losartan 25/50/100mg tablets

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-auro-pharmas-losartan-2550100mg-tablets-1633945560.pdf

    Health Canada
    01 Oct 2021
    Share Share
    Multiple lots of irbesartan, losartan and valsartan drugs recalled
    Multiple lots of irbesartan, losartan and valsartan drugs recalled

    https://www.newswire.ca/news-releases/advisory-multiple-lots-of-irbesartan-losartan-and-valsartan-drugs-recalled-due-to-azido-impurity-824128492.html

    NEWSWIRE
    17 Sep 2021
    Share Share
    Recall of Losacor Tablets and Losacor HCT Tablets
    Recall of Losacor Tablets and Losacor HCT Tablets

    https://www.info.gov.hk/gia/general/202109/16/P2021091600775.htm

    GOV.HK
    17 Sep 2021
    Share Share
    Health Canada Issues Recall of Sandoz Canada's Losartan
    Health Canada Issues Recall of Sandoz Canada's Losartan

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-sandoz-canadas-losartan-1632832579.pdf

    Health Canada
    13 Sep 2021
    Share Share
    Batch recall – Losartan-Mepha, Lactab / Losartan-HCT-Mepha, Lactab
    Batch recall – Losartan-Mepha, Lactab / Losartan-HCT-Mepha, Lactab

    https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/market-surveillance/qualitaetsmaengel-und-chargenrueckrufe/batch-recalls/chargenrueckruf-losartan-mepha-lactab.html

    SWISSMEDIC
    13 Sep 2021
    Share Share
    Health Canada Issues Recall of Sanis' Losartan
    Health Canada Issues Recall of Sanis' Losartan

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-sanis-losartan-1632832674.pdf

    Health Canada
    10 Sep 2021
    Share Share
    Health Canada Issues Recall of Teva's Losartan
    Health Canada Issues Recall of Teva's Losartan

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-tevas-losartan-1630401664.pdf

    HEALTH CANADA
    26 Aug 2021
    Share Share
    MHRA Class 2 Medicines Recall: Irbesartan & Losartan containing products : PSNC
    MHRA Class 2 Medicines Recall: Irbesartan & Losartan containing products : PSNC

    https://www.firstwordpharma.com/node/1838903?tsid=4

    FIRSTWORDPHARMA
    18 Jun 2021
    Share Share
    Losartan is not effective in reducing hospitalization in mild COVID-19
    Losartan is not effective in reducing hospitalization in mild COVID-19

    https://www.sciencedaily.com/releases/2021/06/210618134002.htm

    SCIENCEDAILY
    18 Jun 2021
    Share Share
    UK MHRA recalls contaminated Irbesartan and Losartan batches
    UK MHRA recalls contaminated Irbesartan and Losartan batches

    http://www.pharmabiz.com/NewsDetails.aspx?aid=139364&sid=2

    PHARMABIZ
    17 Jun 2021
    Share Share
    Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs
    Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs

    https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php

    HEALTH CANADA
    15 Jun 2021
    Share Share
    Health Canada Issues Recall of Auro Pharma's Losartan
    Health Canada Issues Recall of Auro Pharma's Losartan

    https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75707r-eng.php

    HEALTH CANADA
    27 May 2021
    Share Share
    Health Canada Issues Recall of Sivem Pharmaceuticals' Losartan
    Health Canada Issues Recall of Sivem Pharmaceuticals' Losartan

    https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75693r-eng.php

    HEALTH CANADA
    26 May 2021
    Share Share
    Health Canada Issues Recall of Teva Canada's Losartan
    Health Canada Issues Recall of Teva Canada's Losartan

    https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75687r-eng.php

    HEALTH CANADA
    25 May 2021
    Share Share
    Enforcement Report - Week of October 14, 2020
    Enforcement Report - Week of October 14, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-14-2020-1602673736.pdf

    FDA
    14 Oct 2020
    Share Share
    Enforcement Report for Week of October 7, 2020
    Enforcement Report for Week of October 7, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-for-week-of-october-7-2020-1602054141.pdf

    FDA
    07 Oct 2020
    Share Share
    Enforcement Report - Week of September 2, 2020
    Enforcement Report - Week of September 2, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-2-2020-1599053980.pdf

    FDA
    02 Sep 2020
    Share Share
    Enforcement Report - Week of April 22, 2020
    Enforcement Report - Week of April 22, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-22-2020-1587564893.pdf

    FDA
    22 Apr 2020
    Share Share
    FDA tags Torrent as key offender in production of tainted blood pressure meds
    FDA tags Torrent as key offender in production of tainted blood pressure meds

    https://www.fiercepharma.com/manufacturing/fda-warning-letter-tags-torrent-as-key-offender-production-tainted-blood-pressure

    Eric Palmer FIERCE PHARMA
    17 Oct 2019
    Share Share
    6 Major Drug Recalls from the Past
    6 Major Drug Recalls from the Past

    https://www.biospace.com/article/6-major-drug-recalls-in-the-past-for-health-concerns/?s=95

    Charlie Harper BIOSPACE
    17 Oct 2019
    Share Share
    Torrent Pharma recalls 74k bottles of hypertension drug from US
    Torrent Pharma recalls 74k bottles of hypertension drug from US

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/torrent-pharma-recalls-74k-bottles-of-hypertension-drug-from-us/articleshow/71562796.cms

    ECONOMIC TIMES
    15 Oct 2019
    Share Share
    Enforcement Report - Week of October 9, 2019
    Enforcement Report - Week of October 9, 2019

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-9-2019-1570607610.pdf

    FDA
    09 Oct 2019
    Share Share
    FDA expands recall of blood pressure meds due to cancer-causing impurity
    FDA expands recall of blood pressure meds due to cancer-causing impurity

    https://bgr.com/2019/09/25/blood-pressure-recall-losartan-fda/

    Mike Wehner BGR
    25 Sep 2019
    Share Share
    Torrent Pharmaceuticals Expands Voluntary Nationwide Recall of Losartan Potassium Tablets
    Torrent Pharmaceuticals Expands Voluntary Nationwide Recall of Losartan Potassium Tablets

    https://www.pharmacompass.com/pdf/news/torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-of-losartan-potassium-tablets-1569033044.pdf

    FDA
    21 Sep 2019
    Share Share
    FDA finds impurity in popular heartburn medicine Zantac that could cause cancer
    FDA finds impurity in popular heartburn medicine Zantac that could cause cancer

    https://www.cnbc.com/2019/09/13/fda-finds-impurity-in-heartburn-medicine-zantac-that-could-cause-cancer.html

    Mallika Mitra CNBC
    14 Sep 2019
    Share Share
    Aurobindo recalls mislabeled statin tablets from the U.S. market
    Aurobindo recalls mislabeled statin tablets from the U.S. market

    https://www.fiercepharma.com/manufacturing/aurobindo-recalls-mislabeled-statin-tablets-off-u-s-market

    K. Blankenship FIERCE PHARMA
    10 Sep 2019
    Share Share
    Enforcement Report - Week of July 17, 2019
    Enforcement Report - Week of July 17, 2019

    FDA
    17 Jul 2019
    Share Share
    Manufacturing Concerns Lead FDA to Pull 31 Apotex ANDAs
    Manufacturing Concerns Lead FDA to Pull 31 Apotex ANDAs

    https://www.raps.org/news-and-articles/news-articles/2019/7/manufacturing-concerns-lead-fda-to-pull-31-apotex?feed=Regulatory-Focus

    Zachary Brennan RAPS
    09 Jul 2019
    Share Share
    Aurobindo gets warning letter over valsartan recall mess
    Aurobindo gets warning letter over valsartan recall mess

    https://www.fiercepharma.com/manufacturing/aurobindo-gets-warning-letter-over-valsartan-recall-mess

    Eric Palmer FIERCE PHARMA
    03 Jul 2019
    Share Share
    Macleods Pharmaceutical Limited Issues Voluntary Nationwide Consumer Level Recall of Losartan Potassium 50mg and Losartan Potassium/Hydrochlorothiazide combination Tablets 50mg/12.5mg, 100mg/12.5mg and 100mg/25mg due to detection of NMBA Impurity.
    Macleods Pharmaceutical Limited Issues Voluntary Nationwide Consumer Level Recall of Losartan Potassium 50mg and Losartan Potassium/Hydrochlorothiazide combination Tablets 50mg/12.5mg, 100mg/12.5mg and 100mg/25mg due to detection of NMBA Impurity.

    FDA
    26 Jun 2019
    Share Share
    Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply
    Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply

    https://www.fiercepharma.com/manufacturing/teva-recall-tainted-blood-pressure-meds-continue-to-show-up-u-s-supply

    Eric Palmer FIERCE PHARMA
    14 Jun 2019
    Share Share
    Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of GSMS Inc. (Losartan Potassium) Due to due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)
    Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of GSMS Inc. (Losartan Potassium) Due to due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)

    https://www.pharmacompass.com/pdf/news/teva-pharmaceuticals-usa-inc-issues-voluntary-nationwide-recall-of-gsms-inc-losartan-potassium-due-to-due-to-the-detection-of-an-impurity-n-nitroso-n-methyl-4-aminobutyric-acid-nmba-1560407242.pdf

    FDA
    10 Jun 2019
    Share Share
    Enforcement Report - Week of May 29, 2019
    Enforcement Report - Week of May 29, 2019

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-29-2019-1559107900.pdf

    FDA
    29 May 2019
    Share Share
    FDA 483s Pile Up in Crackdown on Sartan Manufacturers in India
    FDA 483s Pile Up in Crackdown on Sartan Manufacturers in India

    https://www.raps.org/news-and-articles/news-articles/2019/5/fda-483s-pile-up-in-crackdown-on-sartan-manufactur

    Ana Mulero RAPS
    18 May 2019
    Share Share
    Enforcement Report - Week of May 8, 2019
    Enforcement Report - Week of May 8, 2019

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-8-2019-1557294096.pdf

    FDA
    08 May 2019
    Share Share
    Vivimed Life Sciences Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP
    Vivimed Life Sciences Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP

    https://www.pharmacompass.com/pdf/news/vivimed-life-sciences-issues-voluntary-nationwide-recall-of-losartan-potassium-25-mg-50-mg-and-100-mg-tablets-usp-1556949904.pdf

    FDA
    04 May 2019
    Share Share
    Over 100 lots of losartan tablets recalled after NMBA detected
    Over 100 lots of losartan tablets recalled after NMBA detected

    https://www.in-pharmatechnologist.com/Article/2019/04/29/Torrent-and-Teva-recall-losartan-tablets

    Maggie Lynch IN-PHARMATECHNOLOGIST
    30 Apr 2019
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    DRL Losartan Potassium

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Losartan Potassium

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search